Hypertriglyceridemia promotes dysfunctions in high-density lipoprotein increasing the cardiovascular risk

被引:1
作者
Meneses, Richard Rarison Cavalcante [1 ]
Damasceno, Nagila Raquel Teixeira [2 ]
Cartolano, Flavia De Conti [2 ]
Verde, Sara Maria Moreira Lima [3 ]
Lira, Leticia Gomes [3 ]
Dantas, Mariana Brito [1 ]
Viana, Glautemberg de Almeida [1 ]
da Silva, Mateus Edson [1 ]
de Sousa, Ederson Laurindo Holanda [1 ]
Meneses, Gdayllon Cavalcante [1 ]
Ferreira, Jamile Magalhaes [4 ]
Sampaio, Tiago Lima [1 ,5 ]
Queiroz, Maria Goretti Rodrigues de [1 ]
机构
[1] Univ Fed Ceara, Fac Pharm Dent & Nursing, Dept Clin & Toxicol Anal, Fortaleza, Brazil
[2] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil
[3] Univ Fortaleza, Dept Nutr, Fortaleza, Brazil
[4] Univ Int Integrat Afro Brazilian Lusophony, Redencao, Brazil
[5] Univ Fed Ceara, Fac Farm Odontol & Enfermagem, Dept Anal Clin & Toxicol, Rua Pastor Samuel Munguba 1210, Fortaleza, Ceara, Brazil
关键词
Triglycerides; Lipoproteins; Apolipoprotein A-I; Dyslipidemia; HABITUAL PHYSICAL-ACTIVITY; APOLIPOPROTEIN-A-I; CHOLESTEROL; HDL; DISEASE; EVACETRAPIB; PATHWAYS; OUTCOMES; OBESITY; LDL;
D O I
10.1590/s2175-97902022e20488
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hypertriglyceridemia is associated with several metabolic diseases. The triglycerides (TG) disrupt the cholesterol reverse transport and contribute to increased levels of low-density lipoprotein (LDL). High-density lipoprotein (HDL) acts in cholesterol reverse transport as an anti-inflammatory and antioxidant. This study aims to investigate the role of hypertriglyceridemia in the functionality of HDL. Individuals were divided into 4 groups based on high or low HDL-c and triglycerides levels. Biochemical and anthropometric analysis were performed. This study demonstrated that triglycerides promote dysfunctions on HDL, increasing the cardiovascular risk. Blood pressure was higher in subjects with low HDL. Women presented higher levels of HDL-c and low percentage of fat mass. The highest levels of triglycerides were observed in older age. In addition, high levels of triglycerides were associated with higher total cholesterol and LDL-c levels, non-HDL-c, non-esterified fatty acids, and blood glucose, increasing in the ratio of non-HDL-c/HDL-c and ApoB/ApoA-I. The increase of triglycerides levels progressively impairs the antioxidant capacity of HDL, probably due to a higher occurrence of fatty acid peroxidation in individuals with hypertriglyceridemia. Patients with high HDL and low TG levels increased the Lag Time. Furthermore, a positive correlation was found between TG versus HDL particle size, variables that depend on age and anthropometric parameters.
引用
收藏
页数:13
相关论文
共 48 条
  • [1] [Anonymous], 1995, PHYS STAT UINT ANT
  • [2] The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia
    Backes, James
    Anzalone, Deborah
    Hilleman, Daniel
    Catini, Julia
    [J]. LIPIDS IN HEALTH AND DISEASE, 2016, 15
  • [3] BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
  • [4] Lessons Learned from the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) Trial
    Barter, Philip
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (10A) : 10E - 15E
  • [5] Effects of torcetrapib in patients at high risk for coronary events
    Barter, Philip J.
    Caulfield, Mark
    Eriksson, Mats
    Grundy, Scott M.
    Kastelein, John J. P.
    Komajda, Michel
    Lopez-Sendon, Jose
    Mosca, Lori
    Tardif, Jean-Claude
    Waters, David D.
    Shear, Charles L.
    Revkin, James H.
    Buhr, Kevin A.
    Fisher, Marian R.
    Tall, Alan R.
    Brewer, Bryan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) : 2109 - 2122
  • [6] Antiinflammatory properties of HDL
    Barter, PJ
    Nicholls, S
    Rye, KA
    Anantharamaiah, GM
    Navab, M
    Fogelman, AM
    [J]. CIRCULATION RESEARCH, 2004, 95 (08) : 764 - 772
  • [7] Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
    Besler, Christian
    Heinrich, Kathrin
    Rohrer, Lucia
    Doerries, Carola
    Riwanto, Meliana
    Shih, Diana M.
    Chroni, Angeliki
    Yonekawa, Keiko
    Stein, Sokrates
    Schaefer, Nicola
    Mueller, Maja
    Akhmedov, Alexander
    Daniil, Georgios
    Manes, Costantina
    Templin, Christian
    Wyss, Christophe
    Maier, Willibald
    Tanner, Felix C.
    Matter, Christian M.
    Corti, Roberto
    Furlong, Clement
    Lusis, Aldons J.
    von Eckardstein, Arnold
    Fogelman, Alan M.
    Luescher, Thomas F.
    Landmesser, Ulf
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (07) : 2693 - 2708
  • [8] Cifuentes-Goches JC, 2012, REV MED INST MEX SEG, V50
  • [9] Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study
    da Silva, Isis T.
    Timm, Anelise de Souza
    Damasceno, Nagila R. T.
    [J]. LIPIDS IN HEALTH AND DISEASE, 2013, 12
  • [10] Does lowering triglycerides reduce cardiovascular risk?
    de Moura, Jose Pereira
    [J]. REVISTA PORTUGUESA DE CARDIOLOGIA, 2019, 38 (08) : 543 - 545